A Research On Financial Risk And Prevention Of DX Pharmaceutical Company

The current domestic economic situation is developing rapidly.The environment facing enterprises is complex and changeable.There are also many unstable factors in the business development environment.Financial risk management has become more and more important in the management and business activities of enterprises.Necessary issues in business development.Nowadays,the market competition is becoming more and more fierce,and there are various risks in every link of the whole process from the establishment to the development of the enterprise.If companies want to better deal with risks and reduce the losses caused by risks,it is necessary to fully understand the characteristics and connotations of corporate financial risks,analyze the causes of risks in depth,and then take scientific and reasonable measures to prevent and control financial risks In this way,companies can better improve their ability to resist financial risks and further enhance their financial management level and market competitiveness.With the gradual enhancement of the Chinese people's awareness of their own health management,the aging of China's population is deepening,and the state attaches greater importance to the development of the pharmaceutical industry,and the pharmaceutical industry will usher in unprecedented development opportunities.How pharmaceutical companies survive and develop through this opportunity will be inseparable from the analysis and prevention of financial risks.This article mainly takes DX Pharmaceutical Company as a case study,analyzes the company's financial risks,and proposes preventive measures.First,this article summarizes the current status of research on financial risk management,analysis,and prevention at home and abroad,comprehensively reviews it,and then briefly introduces the meaning and characteristics of financial risk,identification and analysis methods,and the financial industry's financial The characteristics of risk are outlined.Then selected the main financial statement data of DX Pharmaceutical Company from 2014 to 2018,and used financial ratio analysis to calculate and analyze the company's possible debt service risk,operating risk,profit risk and sustainable development risk,and found that The causes of financial risks of DX Pharmaceuticals are not only from external influences,but also from single financing channels,unreasonable debt structure,and conservative investment strategies.Finally,it is proposed that DX Pharmaceuticals can take measures such as expanding financing channels,adjusting debt structure and scale,and strengthening internal management.The conclusion drawn from the analysis is hoped that it can be used as a reference for the financial risk management of other private SMEs.